Abstract:
This invention relates to kits, compositions, and formulations comprising AICA riboside and analogs thereof and methods of using the same. The kits may comprise the compositions and/or formulations within a pH range, in a sterilized form. The kits may further comprise containers with a second therapeutic agent. The kits and compositions herein can be used to prevent morbidity/mortality in a patient or to prevent/treat an ischemic condition, a condition regulated by adenosine, or a condition associated with reduced blood flow to a tissue in a patient.
Abstract:
The present invention provides transdermal administration of AICA riboside, or a prodrugs, analogs, or salts thereof, and/or a blood clotting inhibitor for preventing or reducing adverse side effects in a patient. The type of patient that may benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient undergoing non-vascular surgery, or a fetus during labor and delivery.
Abstract:
The invention relates to membrane modules and applications therefor. In particular, the invention relates to the construction of membrane modules for use in forward osmosis, heat exchange, and distillation processes.
Abstract:
A rotary energy recovery device (11) wherein a multi-channel cylindrical rotor (15) revolves with its end faces (32) juxtaposed in sealing relationship with end surfaces (33) of a pair of flanking end covers (19, 21), and wherein inlet and outlet fluid passageways (27, 29) are provided in each end cover. Fluid may be directed into the rotor channels (16) and allowed to exit therefrom in an axial direction parallel to the axis of the rotor; however, rotor revolution is self-driven as a result of the interior design of the channels (16) which extend axially through the rotor and are shaped so that fluid flow therethrough creates a torque.
Abstract:
A rotary pressure transfer device utilizes a multi-channel, generally cylindrical rotor (15) that revolves with its flat end faces juxtaposed with flat end surfaces of a pair of flanking end covers (19, 21) in which inlet and outlet passageways are provided. The design is such that there are only oblique ramps (65) in the passageways on the high pressure side which create directional flow of liquid to cause rotor revolution in the desired direction. Passageways (27a, 27b) on the low pressure side may be shaped so that there is essentially longitudinal flow entry and discharge of liquid between the channels and the passageways, or passageways (71) may be constructed to create directional flow that slightly retards rotor revolution in such desired direction.
Abstract:
A pressure transfer device for the transfer of pressure energy from a high pressure fluid stream to a lower pressure fluid stream wherein a generally cylindrical housing (61) contains a rotor (63) having a plurality of channels (65) extending axially therethrough that revolves about a central stator (67) or within a surrounding sleeve (73) and a pair of end covers (69, 71) which slidingly and sealingly interface with respective planar end faces (68) of the rotor. The end covers (69, 71) and the accompanying components of the device are constructed so as to allow the channels to be at least twice filled with a high pressure first liquid during each revolution of the rotor and thus discharge twice the volume of a pressurized second liquid than if they were filled only one with high pressure liquid.
Abstract:
This invention relates to kits, compositions, and formulations comprising AICA riboside and analogs thereof and methods of using the same. The kits may comprise the compositions and/or formulations within a pH range, in a sterilized form. The kits may further comprise containers with a second therapeutic agent. The kits and compositions herein can be used to prevent morbidity/mortality in a patient or to prevent/treat an ischemic condition, a condition regulated by adenosine, or a condition associated with reduced blood flow to a tissue in a patient.